A Huge Thank You for Joining Our DAVAMED™ C1 Seminar at CPHI SEA!

A Huge Thank You for Joining Our DAVAMED™ C1 Seminar at CPHI SEA!

We are thrilled to express our sincere gratitude to everyone who participated in our informative seminar, "DAVAMED™ C1: A Cost-Effective, High-Performance, and Direct Compression Tablet Excipient," held on July 11, 2024, at the CPHI South East Asia exhibition at Queen Sirikit National Convention Center (QSNCC).

During the seminar, Dr. Siwarutt Boonyarattanakalin, Assistant Innovation Director, and Dr. Waesarat Soontornchaiboon, Product Innovation Manager, shed light on the significant advantages of DAVAMED™ C1 for pharmaceutical manufacturers.

The Power of DAVAMED™ C1

• Exceptional Binding for Uncompromising Quality: DAVAMED™ C1 boasts exceptional binding capacity, ensuring the creation of strong and consistent tablets. This translates to superior product integrity and quality for your final medication.
• Superior Disintegration for Optimal Effectiveness: This innovative excipient stands out for its superior disintegration properties. DAVAMED™ C1 facilitates rapid drug release, allowing your medication to work as intended and deliver optimal effectiveness.
• Cost-Saving Potential: A Win for Both Quality and Budget: DAVAMED™ C1 goes beyond its performance benefits. Its efficiency can significantly reduce overall production expenses, making it a valuable choice for manufacturers seeking to optimize both quality and budget.

Interested in Learning More?

We hope this seminar provided valuable insights into the advantages of DAVAMED™ C1. Do you have further questions about how DAVAMED™ C1 can benefit your specific formulations? Feel free to contact us directly. Our team is dedicated to supporting you! SMS Innovative Starch Partner!